A composite serum biomarker index for the diagnosis of systemic sclerosis interstitial lung disease: a multicentre, observational, cohort study.

Adelle S JeeIain StewartPeter YoussefStephen AdelsteinDonna LaiSheng HuaWendy StevensSusanna ProudmanGene-Siew NgianIan N GlaspoleYuben P MoodleyJane F BleaselSacha MacanshMandana NikpourJoanne SahharTamera J Cortenull null

Published in: Arthritis & rheumatology (Hoboken, N.J.) (2023)

A composite serum biomarker index, comprising SP-D, Ca15-3 and ICAM-1 may improve the identification and risk-stratification of ILD in SSc patients at baseline.

Keyphrases

interstitial lung disease
systemic sclerosis
rheumatoid arthritis
idiopathic pulmonary fibrosis
clinical trial
study protocol
randomized controlled trial
cross sectional
double blind
bioinformatics analysis